Healthcare Value Capital as of June 30, 2015
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 27 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Proshares Tr Ultsh Nasd Biot | 12.1 | $12M | 400k | 28.72 | |
| Albany Molecular Research | 12.0 | $12M | 567k | 20.22 | |
| Qlt | 9.1 | $8.7M | 2.1M | 4.13 | |
| MannKind Corporation Put Option | 8.8 | $8.4M | 1.5M | 5.69 | |
| Biosante Pharmaceuticals (ANIP) | 8.1 | $7.8M | 125k | 62.05 | |
| Proshares Tr Ultsht Russ2000 | 7.3 | $7.0M | 200k | 34.76 | |
| Astrazeneca Sponsored Adr (AZN) | 6.7 | $6.4M | 100k | 63.71 | |
| Pfizer (PFE) | 5.3 | $5.0M | 150k | 33.53 | |
| Quest Diagnostics Incorporated (DGX) | 5.0 | $4.8M | 66k | 72.51 | |
| CryoLife (AORT) | 4.4 | $4.2M | 370k | 11.28 | |
| Allergan SHS | 3.2 | $3.0M | 10k | 303.50 | |
| Sunesis Pharmaceuticals Com New | 2.8 | $2.7M | 900k | 3.01 | |
| Alliqua Biomedical Com New | 2.3 | $2.2M | 421k | 5.27 | |
| Abbvie (ABBV) | 1.8 | $1.7M | 25k | 67.20 | |
| Aegerion Pharmaceuticals | 1.6 | $1.5M | 80k | 18.98 | |
| Proshares Tr Ii Vix Strmfut Etf Call Option | 1.4 | $1.3M | 100k | 13.42 | |
| Apricus Bioscience | 1.2 | $1.1M | 650k | 1.71 | |
| Amarin Corp Spons Adr New Call Option (AMRN) | 1.0 | $984k | 400k | 2.46 | |
| Sorrento Therapeutics Com New (SRNEQ) | 0.9 | $881k | 50k | 17.62 | |
| Supernus Pharmaceuticals Call Option (SUPN) | 0.9 | $849k | 50k | 16.98 | |
| Fibrocell Science Com New | 0.9 | $831k | 158k | 5.27 | |
| Ariad Pharmaceuticals | 0.9 | $827k | 100k | 8.27 | |
| Cytokinetics Com New (CYTK) | 0.7 | $672k | 100k | 6.72 | |
| Alimera Sciences | 0.5 | $461k | 100k | 4.61 | |
| Zogenix | 0.4 | $420k | 250k | 1.68 | |
| D Stemline Therapeutics | 0.3 | $294k | 25k | 11.76 | |
| XOMA CORP Common equity shares Call Option | 0.3 | $272k | 70k | 3.89 |
